Geode Capital Management’s ProPhase Labs PRPH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-16,262
Closed -$7.28K 4577
2025
Q4
$7.28K Sell
16,262
-14,031
-46% -$39.5K ﹤0.01% 4444
2025
Q3
$139K Buy
30,293
+4,387
+17% +$17K ﹤0.01% 4040
2025
Q2
$101K Buy
25,906
+3,137
+14% +$10.5K ﹤0.01% 4056
2025
Q1
$92.1K Buy
22,769
+2,416
+12% +$11.1K ﹤0.01% 4054
2024
Q4
$154K Buy
20,353
+4,279
+27% +$60K ﹤0.01% 3974
2024
Q3
$389K Buy
16,074
+1,359
+9% +$38.3K ﹤0.01% 3691
2024
Q2
$615K Buy
14,715
+874
+6% +$45.8K ﹤0.01% 3492
2024
Q1
$896K Buy
13,841
+100
+0.7% +$5.07K ﹤0.01% 3406
2023
Q4
$621K Buy
13,741
+1,041
+8% +$47.5K ﹤0.01% 3534
2023
Q3
$555K Sell
12,700
-614
-5% -$36K ﹤0.01% 3562
2023
Q2
$967K Buy
13,314
+1,011
+8% +$82.3K ﹤0.01% 3376
2023
Q1
$937K Hold
12,303
﹤0.01% 3378
2022
Q4
$1.18M Buy
12,303
+668
+6% +$72.2K ﹤0.01% 3271
2022
Q3
$1.31M Buy
11,635
+454
+4% +$52.8K ﹤0.01% 3260
2022
Q2
$1.42M Buy
11,181
+595
+6% +$52.3K ﹤0.01% 3259
2022
Q1
$740K Hold
10,586
﹤0.01% 3752
2021
Q4
$758K Hold
10,586
﹤0.01% 3842
2021
Q3
$550K Buy
10,586
+315
+3% +$18.8K ﹤0.01% 3988
2021
Q2
$636K Buy
10,271
+2,163
+27% +$121K ﹤0.01% 3824
2021
Q1
$599K Buy
8,108
+5,442
+204% +$522K ﹤0.01% 3744
2020
Q4
$244K Buy
+2,666
New +$223K ﹤0.01% 3824

Other funds holding PRPH

Geode Capital Management's PRPH Position: Q1 2026 in Review

Geode Capital Management sold out of ProPhase Labs (PRPH) in Q1 2026, closing a stake of 16,262 shares — an estimated $7.28K sold.

Geode Capital Management first reported a position in PRPH in Q4 2020 and held it in 21 quarters. The position peaked at $1.42M in Q2 2022. 2 funds tracked by Wall St. Rank hold PRPH as of Q1 2026.

  • Geode Capital Management reported no remaining ProPhase Labs position as of Q1 2026 after selling out during the quarter.
  • Geode Capital Management sold 16,262 ProPhase Labs shares in Q1 2026, an estimated $7.28K.
  • Geode Capital Management first reported a position in ProPhase Labs in Q4 2020 and held it in 21 quarters.
  • Geode Capital Management's ProPhase Labs position peaked at $1.42M in Q2 2022.
  • 2 funds tracked by Wall St. Rank held ProPhase Labs as of Q1 2026.

Based on Geode Capital Management's 13F filing for Q1 2026, filed 15 May 2026.